Results 1 to 10 of about 9,902,006 (336)
Journal of Education, Health and Sport, 2023 Background: Graves' disease is responsible for 60-80% causes of hyperthyreosis. An important role in the pathogenesis is played by anti-TSHR immunoglobulins (TRAb), that stimulate TSH receptors leading to excessive hormone synthesis and release by the ...
Natalia Woś +9 more
doaj +3 more sources
Epidemiology, management and outcomes of Graves’ disease—real life data. [PDF]
Endocrine, 2017 PURPOSE: Treatment options in Graves' disease are clearly defined, but management practices and the perceptions of success are varied. The outcomes of treatment in large consecutive cohorts of Graves' disease have not been well characterised.
Allahabadia, A. +3 more
core +2 more sources
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
BMC Endocrine Disorders, 2018 Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning +2 more
doaj +2 more sources
Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy [PDF]
Терапевтический архив, 2022 Radioactive iodine 131I is a theranostic isotope used both for diagnosis and therapy of benign thyroid diseases and thyroid cancer for 85 years. The formation of nuclear medicine is closely linked with the use of 131I.
Marina S. Sheremeta +3 more
doaj +1 more source
Long-term management of Graves disease: a narrative review [PDF]
Journal of Yeungnam Medical Science, 2023 Graves disease (GD) is the most common cause of hyperthyroidism, accounting for more than 90% of cases in Korea. Patients with GD are treated with any of the following: antithyroid drugs (ATDs), radioactive iodine (RAI) therapy, or thyroidectomy.
Hyo-Jeong Kim
doaj +1 more source
The genetics of Graves’ disease
Reviews in Endocrine & Metabolic Disorders, 2023 Graves’ disease (GD) is the commonest cause of hyperthyroidism and has a strong female preponderance. Everyday clinical practice suggests strong aggregation within families and twin studies demonstrate that genetic factors account for 60-80% of risk of ...
Lydia Grixti, L. Lane, S. Pearce
semanticscholar +1 more source
The Occurrence of a Thyroid Storm in a Patient with Recurrent Refractory Peptic Ulcer: A Case Report [PDF]
Journal of Acute Care Surgery, 2022 A thyroid storm is a rare complication of hyperthyroidism. Although a thyroid storm rarely presents with symptoms similar to those of an acute abdomen, and in cases where emergency surgery is needed, the thyroid function test is not performed routinely ...
Kwanhoon Park, Ji Young Jang, Sungho Lee
doaj +1 more source
2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease
European Thyroid Journal, 2021 Hyperthyroidism caused by Graves’ disease (GD) is a relatively rare disease in children. Treatment options are the same as in adults – antithyroid drugs (ATD), radioactive iodine (RAI) or thyroid surgery, but the risks and benefits of each modality are ...
C. Mooij +6 more
semanticscholar +1 more source
Two further cases of Graves’ disease following SARS-Cov-2 vaccination
Journal of Endocrinological Investigation, 2021 Recently, two cases of Graves’ disease after SARS-Cov2 RNA vaccination with tozinameran have been reported [1]. Here, we report two further cases: a late recurrence after 17 years and an initial manifestation. A 71-year-old lady had subtotal resection of
G. Zettinig, M. Krebs
semanticscholar +1 more source
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022 Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj +1 more source